secwatch.observer — SEC 8-K summary
======================================

Issuer:     Acurx Pharmaceuticals, Inc. (ACXP)
CIK:        0001736243
Form:       8-K
Filed at:   2025-06-20T23:59:59+00:00
Accession:  0001104659-25-060902
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Acurx Pharma raises $2.67M via warrant exercise; issues new warrants for ~8.89M shares
--------------------------------------------------------------------------------

- Entered warrant inducement agreement; holder exercised ~4.45M existing warrants at reduced $0.60/share, gross proceeds $2.67M.
- Net proceeds ~$2.3M after fees; used for working capital and general corporate purposes.
- Issued new G-1 and G-2 warrants to purchase up to 8,890,870 shares at $0.425/share; G-1 exercisable immediately, G-2 upon shareholder approval.
- H.C. Wainwright gets 7% fee and warrants to purchase 266,726 shares at $0.75/share.
- Expected close June 20, 2025; 45-day stock issuance restriction and 90-day variable rate transaction restriction.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1736243/000110465925060902/0001104659-25-060902-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1736243/000110465925060902/tm2518285d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-060902

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer